Preview Mode Links will not work in preview mode

Apr 3, 2021

Proceedings from the first of 2 sessions on HER2-positive breast cancer. Featuring perspectives from Dr Erika Hamilton, including the following topics:

  • Introduction and review of SABCS 2020 Educational Session on HER2-targeted therapy (0:00)
  • Case: A 42-year-old premenopausal woman with ER-positive, HER2-positive, node-negative breast cancer — Laurie Matt-Amaral, MD, MPH (7:59)
  • SABCS 2020 Review (22:55)
  • Case: A 43-year-old woman with ER/PR-negative, HER2-positive breast cancer with brain metastasis — Atif Hussein, MD, MMM (28:00)
  • Case: A 73-year-old woman with clinical T4 ER/PR-negative, HER2-positive breast cancer — Dr Matt-Amaral (43:30)
  • Case: A 36-year-old physician with ER/PR-negative, HER2-positive, node-positive breast cancer during pregnancy — Dr Hussein (51:12)

CME information and select publications